Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

From pertussis to tuberculosis: what can be learned?

D L Klein1

  • 1National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, Respiratory Diseases Branch, Bethesda, MD 20892-7630, USA. dk27a@nih.gov.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|June 30, 2000
PubMed
Summary

The development of acellular pertussis vaccines, driven by safety concerns, showcases successful public health leadership and collaboration. This experience offers valuable insights for future vaccine development, including for tuberculosis vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IMMUNITY AND SUSCEPTIBILITY AFTER DIPHTHERIA.

Canadian Medical Association journal·2010
Same author

THE PRACTICAL APPLICATION AND INTERPRETATION OF THE SCHICK TEST: THE DIPHTHERIA ANTITOXIN CONTENT OF THE BLOOD OF THE SHICK-NEGATIVE REACTOR.

Canadian Medical Association journal·2010
Same author

The Term "Dromedary Onset" of Infantile Paralysis, a Misleading One.

Canadian Medical Association journal·2010
Same author

Oxycephaly, with the Report of Two Cases in a Brother and Sister.

Canadian Medical Association journal·2010
Same author

Meningococcus Infection Treated With sulfonamide Drugs.

Canadian Medical Association journal·2010
Same author

Pneumococcal disease and the role of conjugate vaccines.

Microbial drug resistance (Larchmont, N.Y.)·1999

Area of Science:

  • Vaccinology
  • Public Health Policy
  • Infectious Disease Epidemiology

Background:

  • Whole-cell pertussis vaccines dramatically reduced disease but raised safety concerns.
  • Public and media attention on adverse events spurred vaccine development.
  • A shift from whole-cell to acellular pertussis vaccines was necessitated by safety issues.

Purpose of the Study:

  • To analyze the implementation of a national public health agenda for acellular pertussis vaccine development.
  • To understand the factors contributing to the successful licensure of acellular pertussis vaccines.
  • To draw parallels between the pertussis vaccine experience and tuberculosis vaccine development.

Main Methods:

  • Review of public health initiatives and policy implementation.

Related Experiment Videos

  • Analysis of collaborative efforts between government, academia, and industry.
  • Examination of public advocacy and media influence on vaccine policy.

    • Main Results:

    • A national public health agenda successfully integrated concerns about acellular pertussis vaccines into actionable strategies.
    • Collaborative efforts, scientific innovation, and public engagement were crucial for vaccine licensure.
    • The process highlighted the importance of addressing public health concerns effectively.

    Conclusions:

    • The pertussis vaccine experience demonstrates a successful model for vaccine development and public health agenda implementation.
    • Effective leadership and inter-sectoral collaboration are key to overcoming vaccine-related challenges.
    • Lessons learned from acellular pertussis vaccine development can inform tuberculosis vaccine strategies.